← All diseases

Inborn errors of metabolism

Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency

An inherited disease in which the body cannot turn very long-chain fats into energy. The heart, liver and muscles can be affected. Fasting, illness and heavy exercise trigger problems.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

Orphanet has a guideline for emergency doctors for this disease (language: French, English). See on Orphanet

Prepare an emergency card

This page is translated from the Turkish original.

This disease is followed through the “Inborn errors of metabolism” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

The VLCAD enzyme breaks down very long-chain fatty acids. When this enzyme is missing, these fats cannot be turned into energy. Fat waste products that build up can damage the heart, liver and muscles. There are three types, which begin in infancy, in childhood or later.

Which symptoms can occur?

Symptoms vary depending on the type of the disease. Fasting, illness, exercise, heat or cold can trigger episodes.

  • Heart muscle disease and rhythm problems in infancy (in the early type)
  • Floppy muscles and weakness
  • Low blood sugar
  • Enlarged liver (in the childhood type)
  • Muscle pain and cramps brought on by exercise (in the late type)
  • Muscle breakdown and red or brown urine (in the late type)

How is it diagnosed?

The blood is checked for fat waste products called acylcarnitines, and a typical pattern is seen. The diagnosis is confirmed with a genetic test. If needed, a special enzyme test is done on skin or blood cells.

Treatment and care

The basis of treatment is diet. A meal plan low in long-chain fat and containing special fats is followed. Fasting is avoided, and babies are fed often. Avoiding heavy exercise helps prevent muscle breakdown. In the USA, there is an approved special fat treatment for this group of diseases. The heart and blood values are checked regularly. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through recessive inheritance. The mother and father are usually carriers who show no symptoms. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. Recessive diseases can be more common when relatives marry each other. Testing brothers and sisters as well is recommended. Genetic counselling is recommended.

Source: MedlinePlus Genetics: Very long-chain acyl-CoA dehydrogenase deficiency · GeneReviews: Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency

Key facts

How is it inherited?
Autosomal recessive
When does it usually start?
Infancy, Newborn period
Gene(s) involved
ACADVL

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Guides related to this disease

  • Special diets and medical nutrition · Metabolic diet, blood monitoring, medical formula and SGK report, sick-day plan, tube feeding and swallowing problems, school meals, supplement warning

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about VLCAD deficiency

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Inborn errors of metabolism: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:26793

No separate ICD-11 code; WHO classifies this disease under: 5C52.01

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.